Suppliers / Ak Biopharm

Ak Biopharm

South Korea Updated 9 July 2026

Ak Biopharm is an API manufacturer based in South Korea. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
South, South Korea 3007618030

What they file, and where

Molecule Regulators Docs
Icosapent US FDA 1
Icosapent Ethyl US FDA 1

Also appears on these molecule pages

Icosapent Ethyl API

Comparing suppliers?

Choose your molecules and target markets. Ak Biopharm comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability